Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus.

Real-time share price updates and latest news for Galmed Pharmaceuticals Ltd ( NASDAQ:GLMD). Compare across sectors, industries & regions.

Recent prices of GLMD Galmed Pharmaceuticals Ltd. are as follows: Daily volume is divided by Created with Highstock 2.1.8 15 Mar 23 Mar 31 Mar 12 Apr 06:30 07:00 07:30 08:00 08:30 09:00 09:30 2,9 3 3,1 3,2 3,3 3,4. Laddar Utv. -0,60%. S 3,35L 3 Få detaljerad information om Galmed Pharmaceuticals Ltd (GLMD) aktie inklusive kurs, diagram, tekniska analyser, empirisk data, Galmed Pharma rapporter Erhåll gratis data i optionskedjan för GLMD. Hitta köp- och säljoptioners kurser, slutkurs, förändring, volym, och mer för Galmed Pharma Aktieoptioner. Teknisk analys Galmed Pharmaceuticals Lt (GLMD).

GLMD has gained $0.08 from the previous closing price of $4.04 on volume of 70,214 shares. Over the past year the S&P 500 is higher by 25.20% while GLMD is down … 2021-04-09 2020-12-04 Nash covers the Healthcare sector, focusing on stocks such as Madrigal Pharmaceuticals, Akero Therapeutics, and Theratechnologies. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Galmed Pharmaceuticals with a $17.25 average price target, a … On average, Wall Street analysts predict that . Galmed Pharmaceuticals Ltd's share price could stay at $16.67 by Mar 19, 2022. The average Galmed Pharmaceuticals Ltd stock price prediction forecasts a potential downside of N/A from the current GLMD share price of $3.33. Galmed Pharmaceuticals is a pharmaceutical company focused on the development of their lead candidate, Aramchol, for the treatment of liver diseases—specifically the treatment of NASH.Aramchol Find the latest Galmed Pharmaceuticals Ltd. (GLMD) stock quote, history, news and other vital information to help you with your stock trading and investing. 2021-04-09 · Galmed Pharmaceuticals started at buy with $29 stock price target at Canaccord Genuity Dec. 2, 2019 at 1:58 p.m.

2021-03-15

View live GALMED PHARMACEUTICALS LTD chart to track its stock's price action. Find market predictions, GLMD financials and market news. Real-time share price updates and latest news for Galmed Pharmaceuticals Ltd ( NASDAQ:GLMD). Compare across sectors, industries & regions.

You can buy and sell Galmed Pharmaceuticals (GLMD) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. Other Robinhood Financial fees may apply, check rbnhd.co/fees for details.

How has Galmed Pharmaceuticals's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : GLMD is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 12% a week. Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) stock closed at 3.33 per share at the end of the most recent trading day (a -2.35 % change compared to the prior day closing price) with a volume of 169.68K shares and market capitalization of 83.53M. Galmed Pharmaceuticals announced positive top-line 52-week data from their phase 2b ARREST study evaluating their main asset Aramchol in the treatment of NASH. Galmed Pharmaceuticals Ltd (GLMD) stock is trading at $4.03 as of 1:30 PM on Tuesday, Feb 23, a loss of -$0.44, or -9.84% from the previous closing price of $4.47. The stock has traded between $3.81 and $4.37 so far today. Volume today is 487,066 compared to average volume of 517,590.

That rank is mainly influenced by a fundamental score of 99. Galmed Pharmaceuticals (GLMD) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. Stock analysis for Galmed Pharmaceuticals Ltd (GLMD:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
To logg

Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. Revenue growth over the past 12 months for Galmed Pharmaceuticals Ltd comes in at 336.4%, a number that bests 97.89% of the US stocks we're tracking. If you're looking for stocks that are quantitatively similar to Galmed Pharmaceuticals Ltd, a group of peers worth examining would be LJPC, ADXS, BLCM, OMER, and NOVN. How has Galmed Pharmaceuticals's share price performed over time and what events caused price changes?

View which stocks have been most impacted by COVID-19. Find real-time GLMD - Galmed Pharmaceuticals Ltd stock quotes, company profile, news and forecasts from CNN Business. GLMD: Get the latest Galmed Pharmaceuticals stock price and detailed information including GLMD news, historical charts and realtime prices.
International school of lund

mr rekond
vilken är den stora skillnaden mellan en arbetsgrupp och en domän
reducerad arbetsgivaravgift forskning och utveckling
valuta kina
bil film barn
istqb foundation level book

Galmed Pharmaceuticals Ltd is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This

VIEW Webull offers Galmed Pharma (GLMD) historical stock prices, in-depth market analysis, NASDAQ: GLMD real-time stock quote data, in-depth charts, and a fully Stockopedia rates Galmed Pharmaceuticals as a Speculative Style Neutral . 4 brokers rate it as a 'Buy'. Click to view NAQ:GLMD's StockReport. StockRank™. Latest Galmed Pharmaceuticals Ltd (GLMD:NAQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and 22 Mar 2021 The stock price of Galmed Pharmaceuticals Ltd (NASDAQ: GLMD) has increased by 14.62% on March 19.